US Patent 10294304 Chimeric antigen receptors targeting B-cell maturation antigen
Patent 10294304 was granted and assigned to Pfizer Limited on May, 2019 by the United States Patent and Trademark Office.
Is a
Date Filed
March 30, 2016
Date of Patent
May 21, 2019
Patent Application Number
15085317
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10294304 Chimeric antigen receptors targeting B-cell maturation antigen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
